Auriculotherapy for Pre-Operative Anxiety in Kidney Surgery
This study is looking at whether auriculotherapy, a treatment involving stimulating points on the ear, can help reduce anxiety before surgery and potentially lower the need for pain medication afterward. You might be able to join if you are at least 18 years old, are scheduled for an elective partial or full kidney removal (nephrectomy) for cancer, and have a specific level of anxiety (anxiety score between 19 and 29 on a special questionnaire). The study is comparing an active auriculotherapy device (with nitrogen gas) to a placebo device (without nitrogen gas). Researchers will measure how much pain medication (opioids) you use from the day of surgery until discharge or up to 30 days later to see if the treatment is successful. The current recruitment status is unclear.
- Study design
- This is a randomized, placebo-controlled study planning to enroll 60 participants. Participants will be randomly assigned to receive either the active auriculotherapy treatment or a placebo treatment.
- What's involved
- You would complete questionnaires before surgery. The auriculotherapy treatment involves placing a device on specific points on your ear for a short time.
- Compensation
- Not stated in the trial record.
- Follow-up
- Researchers will track your opioid consumption from the day of surgery through discharge or up to 30 days post-operation, whichever comes first.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Auriculotherapy in the Treatment of Pre-Operative Anxiety
At a glance
Conditions
NCT04836936
Where you'd take part
This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
UPMC Shadyside Hospital
Pittsburgh, Pennsylvaniano site contact published
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Study leadership
- Jacques E Chelly, MD · PRINCIPAL_INVESTIGATOR · University of Pittsburgh
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Want this trial checked against your situation?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Opioid ConsumptionDay of surgery through discharge or post-operative day 30, whichever came first
Demonstrate how auriculotherapy using the cryopuncture device changes participant's total opioid consumption following nephrectomy surgery.